Introduction
Intrahepatic infusion of heparin and 5-fluorouracil (5FU) given peroperatively and for one week postoperatively to patients undergoing curative surgery for large bowel cancer has been claimed to prolong survival (Taylor et al. 1979) .
Heparin itself may be beneficial by preventing the deposition of fibrin clot around micrometastases (Hilgard et al. 1972) or by altering the surface charge of tumour cells (Suemas & Ishikawa 1970) , but as it also promotes angiogenesis in transplantable tumour systems (Taylor & Folkman 1982 ) the induction of primary tumours may be facilitated by its use. Thus an increased incidence of metachronous colorectal neoplasms in patients so treated may be seen. This effect of heparin can be neutralized by protamine, a substance which in nature is found only in sperm.
This study was designed to examine the influence of heparin, 5FU (alone or in combination) and protamine on the induction of primary large bowel tumours in rats given the potent colon carcinogen dimethylhydrazine (DMH).
Methods
Syngeneic female wag rats were used. DMH was prepared after the method of Filipe (1975) and administered subcutaneously at a dose of 25 mg/kg for twelve weeks. Previous work has shown that animals given this carcinogen are destined to develop large bowel neoplasms (Martin et al. 1974) but that the earliest tumours do not appear until 16 weeks (Lindstrom et al. 1978) . Thus it is possible to examine the effect of adjuvant therapy given in this interim on subsequent tumour development.
Between weeks 13 and 14 the animals received: no adjuvant therapy (n = 12); heparin 100 units subcutaneously twice daily (n = 20); heparin and 5FU (the latter 2.5 mg intraperitoneally daily) (n = 16); 5FU alone (n = 15); protamine 2 mg subcutaneously twice daily (n = 9).
All animals were killed at 24 weeks. although 15 of the 72 animals (21%) had invasive adenocarcinomas, being multiple in one animal receiving protamine (3 tumours), two receiving heparin (2 each) and one receiving heparin and 5FU (2). Small bowel tumours tended to occur in those animals already noted to have either a large bowel polyp, cancer or both (Table 2) .
Discussion
There was no increased yield of primary tumours in those animals receiving adjuvant heparin despite its reported role in promoting angiogenesis in transplantable tumour systems (Taylor & Folkman 1982) . Whereas a longer course might have revealed some effect, the intention of this study was to examine the effect of a short course equivalent to that used in adjuvant liver perfusion in man (Taylor et al. 1979) . From this viewpoint, any concern that such therapy might promote further large bowel neoplasms would thus seem to be groundless. Adjuvant 5FU in this model has previously been shown to be ineffective in influencing subsequent tumour development (Gilbert et al. 1983) unless it is given directly into the rectum (Narisawa et al. 1980) . The combination of heparin and 5FU similarly has no measurable effect.
By contrast, protamine caused a statistically increased incidence of colonic neoplasms. This is an unexpected finding. Protamine occurs naturally in sperm. The product we used was derived from salmon sperm which is the same source as that shown by Taylor & Folkman (1982) to inhibit angiogenesis in an established experimental tumour (Maugh 1982) . In consequence it is probable that the action of protamine in our model is by a different pathway. It is already known that uncommon anorectal tumours which either have a cloacogenic component- (Cooper et al. 1979 , Leach & Ellis 1981 or are squamous (Li et al. 1982) are associated with anoreceptive homosexuals. An enquiry into the prevalence of rectal adenocarcinoma in homosexual men is indicated.
